Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan + 5-FU/LV in Relapsed Upper GI Tumours
NCT00220064Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jul 2000
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of irinotecan in esophageal carcinoma, Gastric carcinoma (GC), pancreatic carcinoma, esophagogastric junction carcinoma, sponsored by Royal Marsden NHS Foundation Trust. Started Jul 2000; status: completed.
02
Drugs
irinotecan
03
Conditions
esophageal carcinomaGastric carcinoma (GC)pancreatic carcinomaesophagogastric junction carcinoma
Beyond the preview
Go deeper on NCT00220064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00220064.